InvestorsHub Logo
Followers 0
Posts 68
Boards Moderated 0
Alias Born 02/09/2023

Re: None

Saturday, 11/18/2023 3:50:33 AM

Saturday, November 18, 2023 3:50:33 AM

Post# of 7782
Evolus Stifle CC(15/11/23) was very impressive
CEO of EOLS admitted their Extra strength jeuveau cannot be injected on most of areas except one part(except GL i guess)

Please refer to the below transcription
I think the market's still trying to understand what role extra strength plays and whether when you're treating a patient is that full face extra strength or is it maybe one area is and most areas are not because they can't push the dose higher.And I'd say the portion of the market that's even playing with this idea is a very small segment today.Could it expand over time potentially so I think
we're not quite there yet where the economic question is even front and center without understanding how the products will behave in different areas and whether they're mixed.But what we're finding is as we had originally said the original strength is where the majority of the use is in the market today and will continue to be going forward.


Listen to the CC, which shows daxxi's superiority!!
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News